title: [Recent advance in kidney and hypertension research].
authors.forename: Hiroo
authors.initials: H
authors.lastname: Kumagai
authors.forename: Takashi
authors.initials: T
authors.lastname: Oda
authors.forename: Naoki
authors.initials: N
authors.lastname: Ohshima
authors.forename: Hanako
authors.initials: H
authors.lastname: Takechi
authors.forename: Kojiro
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Takahiro
authors.initials: T
authors.lastname: Uchida
authors.forename: Atsushi
authors.initials: A
authors.lastname: Watanabe
authors.forename: Hiroki
authors.initials: H
authors.lastname: Tadano
authors.forename: Hidehito
authors.initials: H
authors.lastname: Matsubara
authors.forename: Masamitsu
authors.initials: M
authors.lastname: Senda
mesh_terms: D000419:Albuminuria / Q000188:drug therapy / Q000209:etiology; D000577:Amides / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002120:Calcium Channel Agonists / Q000627:therapeutic use; D017115:Catheter Ablation; D002560:Cerebrovascular Circulation / Q000502:physiology; D002908:Chronic Disease; D003928:Diabetic Nephropathies / Q000628:therapy; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005650:Fumarates / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications*; D007093:Imidazoles / Q000627:therapeutic use; D007668:Kidney / Q000294:innervation; D007674:Kidney Diseases / Q000209:etiology* / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D013777:Tetrazoles / Q000627:therapeutic use; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D000577:Amides; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D002120:Calcium Channel Agonists; D005650:Fumarates; D007093:Imidazoles; D013777:Tetrazoles; C446481:aliskiren; D000068756:Valsartan; C437965:olmesartan; D014633:Valine